Evidence map›Paper›PMID 42880925›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026

[Risk factors of carotid atherosclerosis in patients with rheumatoid arthritis].

Jiajun Liu, Qing Peng, Yan Liu, Tianzuo Lan, Li Long

Abstract readEnglish Abstract
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiajun LiuDepartment of Rheumatology and Immunology, The First People's Hospital of Guiyang, Guiyang 550000, China.
Qing PengDepartment of Rheumatology and Immunology, Chengdu Second People's Hospital, Chengdu 610072, China.
Yan LiuDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610072, China.
Tianzuo LanDepartment of Rheumatology and Immunology, The First People's Hospital of Guiyang, Guiyang 550000, China.
Li LongDepartment of Rheumatology and Immunology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu 610072, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the characteristics of lipid profile and the risk factors of carotid atherosclerosis (CAS) in patients with rheumatoid arthritis (RA).

methodsSubjects with 216 RA and 214 healthy controls, both without known cardiovascular disease (CVD), were included. CAS plaques were determined by color Doppler ultrasound. Lipid levels were compared between RA patients and healthy controls, and independent risk factors for CAS plaques in the RA patients were analyzed.

results(1) The total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels were lower (

conclusionPatients with RA are more likely to exhibit lipid metabolic abnormalities which are mainly manifested as low cholesterol levels (TC, LDL-C, HDL-C) and high lipid ratios (TC/HDL-C, LDL-C/HDL-C). Such disordered lipid profileis are associated with gender, inflammatory and drug therapy. Age, disease duration, inflammatory status, and diabetes are independent risk factors for CAS plaques in RA patients. Effective control of inflammatory status are important goals of RA management and may also be essential to delay the progression of atherosclerosis.

Indexed as

Arthritis, RheumatoidCarotid Artery DiseasesAdultAgedCase-Control StudiesCholesterolCholesterol, HDLCholesterol, LDLC-Reactive ProteinFemaleHumansMaleMiddle AgedRisk FactorsCholesterolCholesterol, HDLCholesterol, LDLC-Reactive ProteinCardiovascular diseasesCarotid atherosclerosis plaqueLipid profileRheumatoid arthritisRisk factors

Identifiers

PMID42880925
PMCPMC13672217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.